These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 35337077

  • 1. Solids Turn into Liquids-Liquid Eutectic Systems of Pharmaceutics to Improve Drug Solubility.
    Sarraguça MC, Ribeiro PRS, Nunes C, Seabra CL.
    Pharmaceuticals (Basel); 2022 Feb 23; 15(3):. PubMed ID: 35337077
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dissolution enhancement of active pharmaceutical ingredients by therapeutic deep eutectic systems.
    Aroso IM, Silva JC, Mano F, Ferreira AS, Dionísio M, Sá-Nogueira I, Barreiros S, Reis RL, Paiva A, Duarte AR.
    Eur J Pharm Biopharm; 2016 Jan 23; 98():57-66. PubMed ID: 26586342
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Properties of Therapeutic Deep Eutectic Solvents of l-Arginine and Ethambutol for Tuberculosis Treatment.
    Santos F, P S Leitão MI, C Duarte AR.
    Molecules; 2018 Dec 24; 24(1):. PubMed ID: 30586896
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Optimal Design of THEDES Based on Perillyl Alcohol and Ibuprofen.
    Silva E, Oliveira F, Silva JM, Matias A, Reis RL, Duarte ARC.
    Pharmaceutics; 2020 Nov 20; 12(11):. PubMed ID: 33233659
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Formulation of Ascorbic Acid and Betaine-based Therapeutic Deep Eutectic System for Enhanced Transdermal Delivery of Ascorbic Acid.
    Song JE, Jun SH, Ryoo JY, Kang NG.
    Pharmaceutics; 2024 May 20; 16(5):. PubMed ID: 38794349
    [Abstract] [Full Text] [Related]

  • 14. Investigation on drug solubility enhancement using deep eutectic solvents and their derivatives.
    Li Z, Lee PI.
    Int J Pharm; 2016 May 30; 505(1-2):283-8. PubMed ID: 27079143
    [Abstract] [Full Text] [Related]

  • 15. Overview and thermodynamic modelling of deep eutectic solvents as co-solvents to enhance drug solubilities in water.
    Zarei A, Haghbakhsh R, Raeissi S.
    Eur J Pharm Biopharm; 2023 Dec 30; 193():1-15. PubMed ID: 37838144
    [Abstract] [Full Text] [Related]

  • 16. Deep eutectic solvents comprising active pharmaceutical ingredients in the development of drug delivery systems.
    Pedro SN, Freire MG, Freire CSR, Silvestre AJD.
    Expert Opin Drug Deliv; 2019 May 30; 16(5):497-506. PubMed ID: 30955386
    [Abstract] [Full Text] [Related]

  • 17. Controlled release of pharmaceutical agents using eutectic modified gelatin.
    Qu W, Qader IB, Abbott AP.
    Drug Deliv Transl Res; 2022 May 30; 12(5):1187-1194. PubMed ID: 33966177
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of dissolution rate through eutectic mixture and solid solution of posaconazole and benznidazole.
    Figueirêdo CBM, Nadvorny D, de Medeiros Vieira ACQ, Soares Sobrinho JL, Rolim Neto PJ, Lee PI, de La Roca Soares MF.
    Int J Pharm; 2017 Jun 15; 525(1):32-42. PubMed ID: 28412452
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.